dots health software glp-1 Points® in the GLP1 Companion Program: Explained GLP-1 Weight Loss Tracker Progress

Notably, the observed variability in efficacy between agents, particularly in the early phases of treatment, emphasizes the importance of individualized therapeutic strategies, tailored to specific clinical goals, baseline metabolic profiles, and patient preferences

Some insurance plans may require a referral from your primary care physician for coverage purposes

According to the American Diabetes Association, in 2021, the prevalence of diabetes in the US was 11.6%, affecting 38.4 million Americans

People using these medicines can lose more weight than with diet and exercise alone a loss of between 5% and 21% of their body weight can be expected depending on which medicine is taken and how long it is used

Rather than simply offering cash-pay compounded medications (as many telehealth providers do), Ro actively helps members navigate insurance coverage for brand-name GLP-1s